Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R King

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 3, 2007
Investigation of linac-based image-guided hypofractionated prostate radiotherapyTodd Pawlicki, Gwe-Ya Kim, Annie Hsu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 13, 2023
Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β productionAyesha Khan, Richard Killick, Daniel Wirth, et al.
The British Journal of Radiology|October 15, 2015
Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapyAmar U Kishan, Sang J Park, Christopher R King, et al.
Anesthesia and Analgesia|June 20, 2023
User-Centered Design of a Machine Learning Dashboard for Prediction of Postoperative ComplicationsBradley A Fritz, Sangami Pugazenthi, Thaddeus P Budelier, et al.
Urology|May 30, 2017
Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate CancerJohn V Hegde, Darlene Veruttipong, Jonathan W Said, et al.
American Journal of Clinical Oncology|May 25, 2017
Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate CancerNarek Shaverdian, Amar U Kishan, Darlene Veruttipong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2017
Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancerChenyang Wang, Christopher R King, Mitchell Kamrava, et al.
BMJ Open|August 29, 2019
Obstructive sleep apnoea, positive airway pressure treatment and postoperative delirium: protocol for a retrospective observational studyChristopher R King, Krisztina E Escallier, Yo-El S Ju, et al.
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
Cancer|February 9, 2017
Treatment trends for patients with brain metastases: Does practice reflect the data?Kiri A Sandler, Narek Shaverdian, Ryan R Cook, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|May 3, 2007
Investigation of linac-based image-guided hypofractionated prostate radiotherapyTodd Pawlicki, Gwe-Ya Kim, Annie Hsu, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 13, 2023
Masking the transmembrane region of the amyloid β precursor protein as a safe means to lower amyloid β productionAyesha Khan, Richard Killick, Daniel Wirth, et al.
The British Journal of Radiology|October 15, 2015
Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapyAmar U Kishan, Sang J Park, Christopher R King, et al.
Anesthesia and Analgesia|June 20, 2023
User-Centered Design of a Machine Learning Dashboard for Prediction of Postoperative ComplicationsBradley A Fritz, Sangami Pugazenthi, Thaddeus P Budelier, et al.
Urology|May 30, 2017
Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate CancerJohn V Hegde, Darlene Veruttipong, Jonathan W Said, et al.
American Journal of Clinical Oncology|May 25, 2017
Impact of the Primary Information Source Used for Decision Making on Treatment Perceptions and Regret in Prostate CancerNarek Shaverdian, Amar U Kishan, Darlene Veruttipong, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 12, 2017
Pattern of solid and hematopoietic second malignancy after local therapy for prostate cancerChenyang Wang, Christopher R King, Mitchell Kamrava, et al.
BMJ Open|August 29, 2019
Obstructive sleep apnoea, positive airway pressure treatment and postoperative delirium: protocol for a retrospective observational studyChristopher R King, Krisztina E Escallier, Yo-El S Ju, et al.
Urology|April 21, 2007
Optimal timing, cutoff, and method of calculation of preoperative prostate-specific antigen velocity to predict relapse after prostatectomy: a report from SEARCHChristopher R King, Stephen J Freedland, Martha K Terris, et al.
Cancer|February 9, 2017
Treatment trends for patients with brain metastases: Does practice reflect the data?Kiri A Sandler, Narek Shaverdian, Ryan R Cook, et al.
Pageof 12